EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 98 filers reported holding EPIZYME INC in Q3 2016. The put-call ratio across all filers is 7.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,368,000 | +154.3% | 930,718 | +98.9% | 0.20% | +184.7% |
| Q1 2022 | $538,000 | +73.0% | 467,836 | +275.8% | 0.07% | +84.6% |
| Q4 2021 | $311,000 | -15.3% | 124,500 | +73.8% | 0.04% | +5.4% |
| Q3 2021 | $367,000 | -34.3% | 71,652 | +11.7% | 0.04% | -60.2% |
| Q1 2021 | $559,000 | -41.1% | 64,143 | -19.4% | 0.09% | -41.1% |
| Q3 2020 | $949,000 | +209.1% | 79,582 | +221.6% | 0.16% | +409.7% |
| Q1 2019 | $307,000 | +16.7% | 24,742 | -42.1% | 0.03% | +3.3% |
| Q4 2018 | $263,000 | -30.2% | 42,766 | +94.4% | 0.03% | +50.0% |
| Q1 2017 | $377,000 | -1.3% | 22,000 | -43.4% | 0.02% | -4.8% |
| Q3 2016 | $382,000 | – | 38,860 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |